In the last 20 years Canadian university produced some 1200 spin-off companies, out of which 5–6% are still independent and quoted in the stock exchanges. This study analysed these public companies in terms of industry, technologies, regions, universities and growth. The paper finds that the growing companies of the 2000s are most often not in biotechnology, in spite of their frequent support by venture capital. Conversely spin-off companies that grew had often obtained patents and received support from the Industrial Research Assistance Program, a support program for R&D in smaller firms, managed by the National Research Council of Canada. Copyright Springer Science+Business Media, LLC 2006
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Cited by: (explanations, Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.)